Peer review reports
From: Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
Original Submission | ||
---|---|---|
10 Jul 2018 | Submitted | Original manuscript |
31 Aug 2018 | Reviewed | Reviewer Report - Andras Bikov |
7 Oct 2018 | Reviewed | Reviewer Report - G. J. Braunstahl |
28 Dec 2018 | Author responded | Author comments - Takanori Numata |
Resubmission - Version 2 | ||
28 Dec 2018 | Submitted | Manuscript version 2 |
15 Aug 2019 | Reviewed | Reviewer Report - Andras Bikov |
21 Aug 2019 | Reviewed | Reviewer Report - G. J. Braunstahl |
27 Aug 2019 | Author responded | Author comments - Takanori Numata |
Resubmission - Version 3 | ||
27 Aug 2019 | Submitted | Manuscript version 3 |
8 Sep 2019 | Reviewed | Reviewer Report - Andras Bikov |
26 Sep 2019 | Author responded | Author comments - Takanori Numata |
Resubmission - Version 4 | ||
26 Sep 2019 | Submitted | Manuscript version 4 |
Publishing | ||
27 Sep 2019 | Editorially accepted | |
12 Oct 2019 | Article published | 10.1186/s12890-019-0952-1 |